A case of progesterone-induced anaphylaxis, cyclic urticaria/angioedema, and autoimmune dermatitis

I Leonard Bernstein, David I. Bernstein, Zana L. Lummus, Jonathan A. Bernstein
Journal of women's health (2002) · 2011 · vol. 20(4) , pp. 643–648 · doi:10.1089/jwh.2010.2468 · PMID:21417747 · W2094065173
Case report OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-15 ⓘ

This case report details a patient with progesterone-induced anaphylaxis, cyclic urticaria, and autoimmune dermatitis who responded to gonadotropin-releasing hormone agonist therapy, which eliminated specific progesterone antibodies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: Women have exhibited anaphylaxis, urticaria/angioedema, and autoimmune progesterone dermatitis (APD) coinciding with the progesterone premenstrual rise. We report a detailed immunological evaluation of such a woman responsive to a gonadotropin hormone-releasing agonist (GHRA). METHODS: Skin testing, enzyme-linked immunosorbent assays (ELISAs), leukocyte histamine release (LHR), and inhibition assays were performed to demonstrate progesterone immunoresponsiveness. RESULTS: Serum specific-progesterone immunoglobulin G (IgG) and IgE were detected initially and disappeared 6 months after GHRA treatment. Dose-response LHR using patient basophils was observed for different hormones but after 3 months persisted only for 5β-pregnanediol. Preincubation with mouse antiprogesterone monoclonal antibody (PmAb) or mifepristone, a progesterone inhibitor, over a range of doses inhibited specific progesterone-induced LHR. Experiments with varying progesterone concentrations and a fixed dose of anti-IgE resulted in 100% LHR at a concentration as low as 0.016 nmol/mL, which, without anti-IgE, failed to release histamine. CONCLUSIONS: This is the first report of combined recurrent anaphylaxis, cyclic urticaria/angioedema, and APD induced by immunoresponsiveness to progesterone.

My notes (saved in your browser only)

MeSH descriptors

Anaphylaxis Contraceptives, Oral, Synthetic Estrogens Ethinyl Estradiol Norethindrone Progesterone Anaphylaxis Anaphylaxis Angioedema Animals Antibodies, Monoclonal, Murine-Derived Antibodies, Monoclonal, Murine-Derived Autoimmune Diseases Autoimmune Diseases Contraceptives, Oral, Combined Contraceptives, Oral, Combined Contraceptives, Oral, Combined Contraceptives, Oral, Synthetic Contraceptives, Oral, Synthetic Dermatitis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

References (40)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-11T05:18:36.020566+00:00
pubmed
last seen: 2026-10-08T21:08:47.456808+00:00
unpaywall
last seen: 2026-10-26T06:31:53.434635+00:00
License: CC0 · commercial use OK